Showing 1 - 10 of 47
Pharmaceuticals Policy, 2005 has been necessitated due to several developments that have taken place during the course of last few … several other matters having a close bearing on the pharmaceuticals sector have also been included in the policy. …
Persistent link: https://www.econbiz.de/10005487771
The Task Force recommends that price regulation should be on the basis of ‘Essentiality’ of the drug and it should be applied only to formulations and not to upstream products, such as bulk drugs. No effort should be made to impose a uniform price, and only a ceiling price should be...
Persistent link: https://www.econbiz.de/10005528148
The National Early Childhood Care and Education (ECCE) Policy reaffirms the commitment of the Government of India to provide integrated services for holistic development of all children, along the continuum, from the prenatal period to six years of age. The Policy lays down the way forward for a...
Persistent link: https://www.econbiz.de/10010542221
Drug Policy of 1986
Persistent link: https://www.econbiz.de/10009323735
The Drug Policy, 1994 needed to be revised to  meet  the  challenges  brought  about  by  the  competitive  international  pharmaceutical  industry  in  a  globalised  economic  environment,  as...
Persistent link: https://www.econbiz.de/10009358535
Modifications to Drug Policy 1986
Persistent link: https://www.econbiz.de/10009250151
Pharmaceutical Policy of 2002 covering issues of pricing, ,marketing, size of market, quality, production, investment, regulatory authority, monitoring, ethical issues
Persistent link: https://www.econbiz.de/10009250530
This paper reports findings from the survey of India’s textiles and clothing exporters. The survey method has been used to identify and assess the impact of Non-Tariff Measures (NTMs) and the Cost of Compliance (COC) expenditure by the exporters. A structured questionnaire has been used...
Persistent link: https://www.econbiz.de/10008543107
The focus of this paper is India. In line with TRIPS India has introduced a product patent regime in pharmaceuticals … new drugs more suited to the needs of India and other developing countries? Can the innovation capabilities be utilized …
Persistent link: https://www.econbiz.de/10004988399
pharmaceuticals. A limited role played by regulators at the national level, lack of legislative power at central and peripheral levels …
Persistent link: https://www.econbiz.de/10004997989